TTRX
Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.
Turn Therapeutics Inc. (TTRX) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Profitability (F). The rating has held at C for 3 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | C+ (2.5) | D+ (1.8) | F (0.6) | B+ (3.8) | C+ (2.6) | C (2.3) |
| 2026-11-08 | C+ (2.5) | C+ (2.5) | F (0.4) | B+ (3.8) | C+ (2.6) | C (2.4) |
| 2026-11-01 | C+ (2.5) | C+ (2.5) | F (0.4) | A (4.3) | C+ (2.7) | C (2.5) |
| 2026-10-25 | C+ (2.5) | C+ (2.5) | F (0.4) | A (4.2) | C+ (2.6) | C (2.5) |
| 2026-10-18 | C+ (2.5) | C+ (2.5) | F (0.4) | A- (3.9) | F (0.0) | C- (1.9) |